Evidence map›Paper›PMID 31832141›Full record

ReviewClinical and translational allergy2019

Highlights and recent developments in skin allergy and related diseases in EAACI journals (2018).

C A Akdis, J Bousquet, C E Grattan, P A Eigenmann, K Hoffmann-Sommergruber, I Agache, M Jutel

Erratum issuedAbstract readReview
In one paragraph

Review in Clinical and translational allergy, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors.

C A Akdis1Swiss Institute of Allergy and Asthma Research (SIAF), University Zurich, Davos, Switzerland.
J BousquetMACVIA-France, Fondation Partenariale FMC VIA-LR, CHU Arnaud de Villeneuve, 371 Avenue du Doyen Gaston Giraud, 34295 Montpellier Cedex 5, France.ORCID 0000-0001-9226-7762
C E Grattan6St John's Institute of Dermatology, Guy's Hospital, London, UK.
P A Eigenmann7Pediatric Allergy Unit, University Hospitals of Geneva, Geneva, Switzerland.
K Hoffmann-Sommergruber8Department of Pathophysiology and Allergy Research, Medical University of Vienna, Vienna, Austria.
I Agache9Transylvania University Brasov, Brasov, Romania.
M JutelALL-MED Medical Research Institute, Wroclaw, Poland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The European Academy of Allergy and Clinical Immunology (EAACI) supports three journals: Allergy, Paediatric Allergy and Immunology as well as Clinical and Translational Allergy. The major goals of EAACI include (i) supporting health promotion in which the prevention of allergy and asthma plays a critical role and (ii) disseminating the knowledge of allergy to all stakeholders including the EAACI junior members. Substantial progress was made in 2018 in the identification of basic mechanisms of atopic dermatitis and urticaria and the translation of these mechanisms into clinics. Many large epidemiologic studies and meta-analyses have been the highlights of the last year.

Indexed as

Atopic dermatitisEAACIUrticaria

Identifiers

PMID31832141
PMCPMC6864939

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.